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Summary 
 
Cystinuria, one of the first recognized inborn errors of metabolism, has been reported in 
many dog breeds. The objective was to determine urinary cystine concentrations, inheritance 
and mutations in the SLC3A1 and SLC7A9 genes associated with cystinuria in 3 breeds: 
Mixed and purebred Labrador Retrievers (n=6), Australian Cattle Dogs (6), Miniature 
Pinschers (4) and one mixed breed dog with cystine urolithiasis, relatives and control dogs. 
Urinary cystinuria and aminoaciduria was assessed and exons of the SLC3A1 and SLC7A9 
genes were sequenced from gDNA. In each breed male and female dogs, independent of 
neuter status, were found to form calculi. A frameshift mutation in SLC3A1 resulting in a 
premature stop codon was identified in autosomal-recessive (AR) cystinuria in Labrador 
Retrievers and mixed breed dogs. A 6 bp deletion removing 2 threonines in SLC3A1 was 
found in an autosomal-dominant (AD) cystinuria with a more severe phenotype in 
homozygous than heterozygous Australian Cattle Dogs. A missense mutation in SLC7A9 was 
discovered in an AD cystinuria in Miniature Pinschers with only heterozygous affected dogs 
observed to date. Breed specific DNA tests were developed. These studies describe the first 
AD inheritance and the first putative SLC7A9 mutation to cause cystinuria in dogs and 
expand our understanding of this phenotypically and genetically heterogeneous disease, 
leading to a new classification system for canine cystinuria and better therapeutic 
management and genetic control in these breed. 
 
 
Keywords: metabolic disease, uroliths, nephropathy, hereditary disease 
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Zusammenfassung 
 
Die Cystinurie, eine der zuerst beschriebenen erblichen Stoffwechselerkrankungen, wurde bei 
vielen Hunderassen dokumentiert. Ziel war die Bestimmung der Cystinausscheidung im Urin, 
Erbgänge und Mutationen in den Genen SLC3A1 und SLC7A9 im Zusammenhang mit einer 
Cystinurie bei 3 Rassen: Labrador Retriever und –Mischlinge (n=6), Australian Cattle Dogs 
(6), Zwergpinscher (4) und ein Mischling mit Cystinsteinen, sowie verwandte Tiere und 
Kontrollen. Dazu wurde die Ausscheidung von Cystin und anderen Aminosäuren mit dem 
Harn bestimmt und die Exons der Gene SLC3A1 und SLC7A9 aus gDNA sequenziert. 
Hunde jeder Rasse bildeten unabhängig von Geschlecht und Kastrationsstatus Cystinsteine. 
Eine Nonsense-Mutation in SLC3A1, resultierend in einem vorzeitigen Stop-Codon, wurde 
bei einer autosomal-rezessiven Cystinurie bei Labrador Retrievern und –Mischlingen 
gefunden. Eine Deletation von 6 bp mit dem Fehlen von zwei Threonin Molekülen in 
SLC3A1, wurde bei einer autosomal-dominanten (AD) Cystinurie mit stärker ausgeprägtem 
Phänotyp bei homozygoten als heterozygoten Australian Cattle Dogs festgestellt. Eine 
Missense-Mutation in SLC7A9 bei einer AD Cystinurie mit bisher nur heterozygot erkrankten 
Tieren, wurde beim Zwergpinscher beobachtet. Rassespezifische DNA-Tests wurden 
entwickelt. Diese Studie beschreibt erstmals AD Erbgänge der Cystinurie des Hundes, sowie 
eine ursächliche Mutation im Gen SLC7A9. Sie erweitert das Verständnis dieser phäno-und 
genotypisch variablen Erkrankung und resultiert in einer neuen Klassifikation der caninen 
Cystinurie. 
 
 
Schlüsselwörter: Metabolische Erkrankung, Harnsteine, Nephropathie, Erbkrankheit 
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Abbreviations 
 
AD   autosomal dominant 
AR   autosomal recessive 
bp  base pair(s) 
DNA  deoxyribonucleic acid 
EDTA  ethylenediaminetetraacetic acid 
COLA  cystine, ornithine, lysine and arginine 
PCR  polymerase chain reaction 
SNP  single nucleotide polymorphism 
UV  ultra violet
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Introduction 
 
Cystinuria (OMIA 000256-9615) is one of the first inborn errors of metabolism recognized 
by Sir Archibald Garrod 
1,2
 and is an inherited selective renal transport defect 
3,4
 involving 
cystine and the dibasic amino acids ornithine, lysine, and arginine, collectively known as 
COLA.
4
  In contrast to the normal near complete reabsorption of COLA in the proximal renal 
tubules, these amino acids reach high concentrations in the urine, where only cystine causes a 
clinical problem.
5
 The low solubility of cystine in acidic and neutral urine may lead to the 
formation of cystine crystals and uroliths in the urinary tract,
6
 which result clinically in 
stranguria, hematuria, urinary obstruction and renal failure.
7,8
   
In 1823, cystinuria was the first reported “inborn error of metabolism” in dogs,
9
 and 
now is known to affect >70 canine breeds according to reports of veterinary urolith analysis 
laboratories worldwide.
10,11
 Based upon the varied clinical presentations, metabolic 
derangements and genetic studies, we previously divided canine cystinuria into type I and 
non-type I cystinuria:
12
 type I cystinuria, as characterized in Newfoundlands and Landseers,
13
 
causes massive aminoaciduria of COLA and juvenile to adult calculi formation. It is an 
autosomal recessive trait affecting both males and females independent of neutering status, 
although more often cystinuric males show clinical signs of urinary obstruction, presumably 
due to anatomical differences between males and females.
13
  In non-type I cystinuria, 
exemplified by Mastiffs and related breeds, Scottish Deerhounds and Irish Terriers, only 
intact adult males show variable degrees of aminoaciduria and the average age of stone 
formation is later than in Newfoundlands.  The molecular basis and mode of inheritance of 
non-type I cystinuria remain unknown, but is not an X-chromosomal disorder and appears to 
be testosterone dependent.
 a,14
  
  7 
Two genes, SLC3A1 and SLC7A9 encode the polypeptide subunits of b
0,+
, the basic 
amino acid transporter system (for reviews see 
4,15,16
).  The SLC3A1 gene encodes the 
extracellular heavy chain referred to as rBAT, and the SLC7A9 gene the light chain called 
b
0,+
AT.
3
 The subunit b
0,+
AT has 12 transmembrane domains typical of cell membrane 
transporters  and heterodimerizes with rBAT exclusively to form the COLA amino acid 
transporter.
17
 Among all the cystinuric dogs, to date only one mutation in SLC3A1, an early 
stop codon precluding the production of the rBAT protein, therefore leading to the loss of b
0,+
 
function, was identified in cystinuric Newfoundlands in 2000.
18
 And while the disease was 
widely recognized in the breed, screening programs for the mutation have drastically reduced 
the incidence of cystinuria in Newfoundlands and Landseers worldwide.  
We report here the clinical, metabolic and molecular genetic characterization of 
cystinuric Labrador Retrievers, Australian Cattle Dogs, Miniature Pinschers and mixed breed 
dogs. We identified two new SLC3A1 mutations, one inherited in an autosomal dominant 
fashion and the other showing autosomal recessive inheritance, and the first SLC7A9 
mutation found in dominantly inherited cystinuria in dogs, thereby characterizing the genetic 
heterogeneity of cystinuria in dogs at the gene mutation level. Because our data now 
demonstrate multiple genetic etiologies and modes of inheritance for canine cystinuria, we 
propose a new expanded classification system for canine cystinuria. 
  8 
Materials and Methods 
 
Animals and Samples 
Dogs of 3 different breeds and mixed breed dogs presented with cystine uroliths and 
relatives of these dogs (Labrador Retrievers n=11, Australian Cattle Dogs n=10, Miniature 
Pinschers n=13, mixed breed dogs n=3) were included in the study. Free catch urine and 
EDTA-anticoagulated blood samples were sent chilled or frozen to the Metabolic Genetics 
Laboratory at the University of Pennsylvania.
b
 Archival urine and EDTA-blood samples were 
used as controls. Medical records and pedigree information were reviewed, as far as 
provided. These studies were approved by the Institutional Animal Care and Use Committee 
of the University of Pennsylvania. 
 
Urinary Metabolic Tests 
Urine samples were chilled or frozen until analysis for cystine using the semi-
quantitatively cyanide-nitroprusside method and/or quantitatively by complete amino acid 
analysis using an automated amino acid analyzer
c
 with ninhydrin detection validated for 
canine urine samples. Reference ranges were created using free-catch urine samples obtained 
from adult dogs of breeds known not to be renal stone formers. The urinary nitroprusside test 
is a simple screening test detecting the presence of saturing concentrations of >312 !mol 
cystine / l urine, based upon a chemical reduction reaction of cystine to cysteine by cyanide. 
A positive reaction is visible as a color change of the urine from yellow to magenta red.
19
 
 
Molecular Genetic Studies 
Genomic DNA was extracted from EDTA-blood samples using the Midi kit
d
 or 
phenol/chloroform extraction.  Primer pairs to amplify exons and surrounding splicing 
  9 
consensus sequences of the SLC3A1 and SLC7A9 genes were designed using the UCSC-
genome primer browser
e
 or the LaserGene DNA sequence analysis package
f
 and optimal 
annealing and amplification conditions were established (Table 1). 
SLC3A1 exons 2-10 were amplified in a polymerase chain reaction (PCR) of a total 
volume of 50 !l containing 35.5 !l of DNAse-free water, 5 !l of 10X Ex Taq Buffer, 5 !l of 
dNTPs (2.5 mM each), 1 !l each of the 40 !M forward-and reverse primers, 0.5 !l of an 
Takara Ex Taq HS Polymerase (5 U/!l)
g
 and 2 !l of the gDNA template. For the 
amplification of SLC3A1 exon 9, 12.5 !l of an EmeraldAmp Max HS PCR Master Mix (2X)
g 
was set up with 9.5 !l of DNAse-free water, 1 !l each of the forward and reverse primer (100 
mM) and 1 !l of the gDNA template.  
For SLC7A9 exons 9-11 and 13, the same PCR reaction containing the Takara Ex Taq 
HS Polymerase
g
 was used.  For the DNA fragments containing exons 2, 7-8 and 12, a 30 !l 
PCR mix containing 1X Buffer B,  with 10 !l of DNAse-free water, 5 !l 5X Buffer B, 5 !l 
dNTPs , 1 !l each of the 20 !M forward- and reverse primers, 1 !l AkkuPrime
h
 GC- Rich 
DNA Polymerase (2 U/!l) and 2 !l of the gDNA template. For SLC3A1 exon 1 as well as 
SLC7A9 exons 1 and 3-6, a different PCR mix of 25 !l total volume containing 5 !l of 
DNAse-free water, 12.5 !l 2X Xtreme buffer, 5 !l dNTPs (2 mM each), 0.75 !l each of the 
20 !M forward-and reverse primers (for SLC3A1 exon 1 0.375 !l of a 100mM primer pair), 
0.5 !l Novagen KOD Xtreme Hot Start DNA Polymerase (1 U/!l)
i
 and 0.5 !l of the gDNA 
template was used.  
All amplifications with the Ex Taq Hot Start Polymerase
g
 and the GC-rich 
polymerase
h
 were performed with a PCR Mastercycler proS
j
 and the following sequential 
steps: initial denaturation at 98°C for 3 minutes, followed by 35 cycles of amplification with 
denaturation at 98°C for 45 seconds, annealing of primers at corresponding temperature for 
30 seconds and extension at 72°C for 30 seconds with a final extension at 72°C for 7 minutes. 
  10 
For the PCR-reaction with Novagen KOD Xtreme Hot Start DNA Polymerase,
i
 the 
amplification was performed using an GeneAmp PCR system 2700
k
 with the following 
sequential steps: initial denaturation at 94°C for 2 minutes, followed by 35 cycles of 
amplification with denaturation at 98°C for 1 second, annealing of primers at 60°C for 10 
seconds and extension at 68°C for 1 minutes and 37 seconds, except for the amplification of 
SLC3A1 exon 9. Here, a touchdown PCR with an initial denaturation at 95°C for 3 minutes, 
10 cycles of denaturation at 95°C for 30 seconds, and a touchdown annealing for 1 minute 
starting at a temperature of 65°C and lowering by 1°C after each cycle and an extension for 1 
minute at 72°C, followed by another 25 cycles with an annealing at 55°C for 30 seconds, was 
performed on the same instrument. 
Following amplification, each PCR product together with a loading dye was 
electrophoresed on a 2% agarose gel containing ethidium bromide. Under UV light exposure, 
observed DNA bands were excised and purified using a QIAquick Gel Extraction kit
d
, and 
submitted for sequencing at the University of Pennsylvania’s Core DNA Sequencing Facility 
on an Applied Biosystems
k
 instrument. The sequences were compared to the CanFam 3.1 
canine reference genome assembly using the NCBI-Blast-tool
l
 and chromatograms were 
displayed for visual examination using the ChromasPro
m
 sequence viewer.  All exonic and 
intronic flanking as well as the 5’ and 3’ untranslated regions of both genes were analyzed. 
Genetic nomenclature is in accordance with the Guidelines and Recommendations for 
Mutation Nomenclature by the Human Genome Variation Society.
20
 
 
DNA Mutation Tests 
TaqMan SNP genotyping assays
j
 were developed for the mutations found in Labrador 
Retrievers and Miniature Pinschers. For the deletion found in Australian Cattle Dogs, a PCR 
assay was developed, using the specific primer pair (5’GTTTCCAAAGGACACGGTCAC’3 
  11 
and 5’GTTACCTGTATCTCCCAGGCTC’3), that discriminates the normal and affected 
alleles by electrophoresis on a 5% polyacrylamide gel. 
 
Breed and Mixed Breed Determination 
Most dogs were considered as purebred as reported by owners and with registration 
and pedigree information provided in some cases. Breed or composition of specific mixed 
breed dogs was assessed by the Wisdom Panel Test.
n
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Results 
 
Clinicopathological Findings 
Dogs with cystine urolithiasis included 4 purebred (LABR 1-4) and 2 mixed breed 
(LABX 1-2) Labrador Retrievers, 6 Australian Cattle Dogs (AUCD 1-6), one mixed breed 
dog (MIXB 1), and 4 Miniature Pinschers (MINP 1-4). Control dogs with no clinical signs of 
cystinuria included Labrador Retrievers (LABR 5-7 related to LABR 4 and LABR 8-11), 
Australian Cattle Dogs (AUCD 7-10 related to AUCD 2) and Miniature Pinschers (MINP 5-
13, all related to MINP 1-4) and historical urine amino acid analyses. Uroliths, surgically 
removed by cystotomy, consisted of 100% cystine, based on crystallographic analyses by 
various commercial urolith laboratories.  
All 5 male mixed and purebred Labrador Retrievers, 4 of them castrated by at least 3 
months prior to testing, developed voiding problems due to cystine calculi at ages ranging 
from 6 to 14 months. The spayed female LABR 4 showed no evidence of cystine calculi in 
bladder- and kidney until 7 years of age, requiring unilateral nephrectomy and cystotomy at 
that time (Table 2). Available dogs related to LABR 4 did not show any urinary tract signs 
and were 7, 12 and 13 years old at the time of testing. Dogs in an additional Labrador family 
(LABR 8-11), related to a cystine stone former that was not available for the study, also 
showed no urinary tract signs.  
Among the Australian Cattle Dogs studied, all from different parts of the United 
States, 2 neutered males and one intact male developed urinary tract signs due to cystine 
uroliths within their first year of life, whereas the 2 other affected males and the female did 
not show urinary obstruction until 4-5 years of age (Table 2). The available dogs related to 
AUCD 2 did not show any clinical signs of cystinuria.  
  13 
In addition, a male castrated mixed-breed dog (MIXB 1), obtained from a shelter, 
experienced urinary obstruction due to cystine calculi twice by 2 years of age. This dog has 
been managed with urinary alkalization, diet, and tiopronin
o
 and has since not obstructed 
again as of the time of this study, at age 5 years.  
The family of 13 Miniature Pinschers (MINP 1-13) was comprised of 7 male dogs, 
one of them neutered, and 6 intact females. Two males, one intact and one neutered, as well 
as 2 females had been diagnosed with problems urinating due to cystine uroliths and 
crystalluria.  MINP 1 first developed signs of cystinuria at 11 months of age, whereas the 
other male and the females were first recognized as affected at the age of 2 years and older 
(Table 2). All other related dogs showed no clinical signs of cystinuria. 
 
Metabolic Urine Analyses 
Urine samples from Labrador Retrievers and Australian Cattle Dogs with a history of 
cystine calculi formation were all strongly positive by the cyanide-nitroprusside test, whereas 
this test was negative for the related dogs of either breed and also all unrelated dogs, if tested.  
These stone formers included male and females dogs and the cystine test results were positive 
even after neutering the dogs. For the Miniature Pinschers urine samples were not available 
for the cyanide-nitroprusside test. 
Similarly quantitative amino acid determination revealed increased urinary cystine, 
ornithine, lysine and arginine concentrations and thus high COLA values (Table 2), but 
normal urinary concentrations for other amino acids (not shown). In one stone-forming dog 
(LABR 4) cystine was found by the nitroprusside test, but gave a normal quantitative cystine 
result, perhaps due to precipitation of excess cystine in the urine during storage or laboratory 
error. Interestingly, among the early Australian Cattle Dog stone formers the COLA values 
were at least twice as high as those from the male later stone formers. Urinary nitroprusside 
  14 
test results were negative (COLA values were not determined) for all related Labrador 
Retrievers and Australian Cattle Dogs that showed no clinical signs of cystinuria. In the 
Miniature Pinschers, all 4 cystine stone formers as well as 1 other male were strongly 
cystinuric, and 1 male and 2 females had moderate elevations of COLA concentrations. The 
degree of elevation of urinary COLA concentrations did not correlate with the observation of 
stone formation or the age. Of note, some cystinuric Miniature Pinschers showed higher urine 
cystine concentrations than the combined concentrations for ornithine, lysine, and arginine.   
 
DNA Sequencing and Mutation Analyses 
All exonic DNA sequence differences in SLC3A1 and SLC7A9 gene between the 
CanFam 3.1 canine reference genome assembly and cystine stone-forming dogs LABR 2, 
LABX 1, AUCD 1 and 5, MIXB 1 as well as MINP 8 are shown in Table 3. Neither the 
mutation found to cause cystinuria in the Newfoundlands,
18
 nor the amino acid exchanges 
formerly described polymorphisms in exon 6 (I192V) and 10 (S698G) of SLC3A1 and exon 5 
(A217T) of SLC7A9 in English Bulldogs were observed in any of the dogs studied here.
21
 
The sequence differences resulting in cystinuria are below detailed for each breed studied. 
Mixed and Purebred Labrador Retrievers - A homozygous 1 bp deletion 
(c.350delG) in exon 1 of the SLC3A1 gene was found in the DNA from the one cystinuric 
Labrador Retriever and one Labrador mixed breed dog (LABR 2 and LABX 1). The deleted 
guanine in codon GGC (coding for glycine) causes a shift of the open reading frame 
(p.Gly117Alafs*41) leading to a premature stop codon 41 codons later (Fig. 1A).  
Based on SLC3A1 exon 1 sequencing, the additional 3 cystinuric Labrador Retrievers 
as well as the cystinuric Labrador-mixed breed dog were also homozygous for the single base 
deletion. Among the related non-cystinuric Labrador Retrievers tested, the parents of the 
affected LABR 4 were heterozygous for the deletion, while the 1 available littermate had 2 
  15 
normal alleles. In the unrelated Labrador family (LABR 5-8) 1 parent and 1 daughter were 
carriers for the mutation. Exon 1 of the canine SLC3A1 contains 2 polymorphic hexamer 
repeat sequences, GAGCCC and GTCGGG, which have been shown to be polymorphic 
within and between dog breeds.
18,21
 All sequenced Labrador Retrievers and Labrador 
Retriever mixed breed dogs were homozygous and had 8 copies of the GAGCCC sequence 
and 6 copies of the GTCGGG sequence (referred to as haplotype 8/6).  
Australian Cattle Dogs – A heterozygous deletion of 6 bases (c.1095_1100del) was 
found in exon 6 of the SLC3A1 gene from AUCD 2. This deletion removes 2 of 3 consecutive 
threonine residues (p.Thr366_Thr367del) from the rBAT polypeptide encoded by this gene 
(Fig. 1B). Sequencing of this exon in other cystinuric Australian Cattle Dogs showed that 4 
were homozygous (AUCD 1, 3-4 and 6) and 2 were heterozygous (AUCD 2 and AUCD 5) 
for this deletion. Two dogs related to AUCD 2 were homozygous for the normal allele, 
whereas 1 young son was also heterozygous for the deletion (lost to follow up and no urine 
available for study). Only the 7/6 haplotype for the hexamer repeats in exon 1 was observed 
in the sequenced Australian Cattle Dogs.  
Mixed Breed Dog - Interestingly, the cystinuric dog MIXB 1 had the same 
homozygous 6 bp deletion in exon 6 of the SLC3A1 gene as found in the Australian Cattle 
Dogs. This was an unexpected finding, given the physical appearance of MIXB 1. Because of 
the simple sequence repeat nature of the 6 bp deletion, potentially predisposing this region for 
a high mutation rate, we examined the possibility that the same deletion event occurred 
independently in Australian Cattle Dogs and in the ancestors of MIXB 1. Examination of all 
exons and some flanking intronic regions in the SLC3A1 gene revealed that this dog was 
entirely homozygous for the same silent and intronic polymorphisms (Table 3) observed in 
the homozygous affected Australian Cattle Dogs, compared to the canine reference genome 
sequence. The hexomeric repeat haplotype was 7/6 as seen in the Australian Cattle Dogs.   
  16 
 Miniature Pinschers – In exon 9 of the SLC7A9 gene, a single base change 
(c.964G>A) was detected, causing the substitution of a large positive charged, hydrophilic 
arginine for the very small, hydrophobic glycine residues, (p.Gly322Arg) (Fig. 1C). All 
additional cystinuric Miniature Pinschers (as defined by stone formation or elevated urine 
COLA levels) studied were found to be heterozygous for this missense mutation, whereas all 
dogs homozygous for the normal allele had normal urinary COLA levels and no history of 
calculi formation (Fig. 2). The exonic sequence of the SLC3A1 gene did not reveal any 
mutations and the observed number of hexomeric repeats in exon 1 was 7/5 in all Miniature 
Pinschers tested. 
 
DNA Mutation Tests 
The presence of the mutations in Labrador Retrievers and Miniature Pinschers can be 
easily detected by the established TaqMan SNP genotyping assays
k
 and retesting all studied 
DNA samples by this method confirmed the genotype results from sequencing. 
A simple DNA amplification of a small region surrounding the 6 bp deletion found in 
Australian Cattle Dogs, readily differentiates between the normal and mutant allele due to the 
6 bp fragment size difference and can be used as a screening test to discriminate 
heterozygous or homozygous affected or normal genotypes (Fig. 3). 
 
Breed and Mixed Breed Determination 
Because these molecular genetic studies included purebred and mixed breed dogs, the 
breed composition of some dogs was examined using the Wisdom Panel Test.
n
 The cystinuric 
Labrador mixed breed dogs were reported to have Labrador contributions. The 2 
heterozygous cystinuric Australian Cattle Dogs were found to be purebred Australian Cattle 
Dogs, as stated by their owners.  
  17 
The mixed breed dog (MIXB 1), weighing 18.5 lbs and measuring 16.5 inches at the 
shoulder with a white soft long hair coat, had a breed constitution of 1/4 each from Miniature 
Poodle, Chihuahua, and Shi Tzu, with several other breeds constituting the last quarter, but 
no evidence of Australian Cattle Dog. Most interesting despite the many breeds involved, this 
dog had a high degree of homozygosity (69%) for the informative 312 single nucleotide 
polymorphism (SNP) markers, which typically is seen with inbred and purebred dogs 
according to extended report of the breed testing results.  
The Miniature Pinschers were not subjected to breed testing as these dogs were 
registered with official pedigrees showing common ancestry. Interestingly, these dogs were 
from Europe (mostly from Germany) and belonged to a single 5 generations pedigree (Fig. 
2). 
  18 
Discussion 
 
While cystinuria is one of the classic inborn errors of metabolism and has been 
described in several species,
12
 the disease is phenotypically heterogeneous in humans and 
animals, and its molecular basis is not yet completely understood.
12,22,23
 The genetic studies 
in 3 breeds presented here document some of the heterogeneity in canine cystinuria.  We 
identified a previously undescribed mutation in the SLC3A1 gene in an autosomal recessive 
form of the disease, phenotypically and genetically similar to that previously described in 
Newfoundland dogs.
13,18
  We also characterized the first examples of both SLC3A1 and 
SLC7A9 gene mutations that are associated with autosomal dominant patterns of inheritance 
of cystinuria in dogs. These genes together encode the heteromeric b
0,+  
amino acid 
transporter.
16,17
 Screening for hexagonal crystalluria on microscopic sediment evaluation,
24
 
crystallographic calculi analysis, urinary nitroprusside test for cystine and/or amino acid 
quantitation for increased COLA readily detected the cystinuric dogs in this study, and 
genetic tests can now also be used. Unfortunately, we did not have access to kidneys of any 
cystinuric dogs for protein and mRNA studies, but computer modeling of the observed 
mutations and current knowledge of the protein structure and functional domains strongly 
suggest a defective reabsorption of the transporter system b
0,+
. Based upon the genetic 
findings, we propose a novel classification nomenclature for cystinuria in dogs (Table 4), 
which also has important implications for management and genetic control. 
Similar to the cystinuria in the Newfoundland (and Landseer) breed, which was the 
first cystinuria characterized at the molecular level in any dog breed, cystinuria in Labrador 
Retrievers is caused by an early frameshift mutation (c.350delG) in the SLC3A1 gene, also 
leading to a premature stop codon that truncates the rBAT protein to 157 amino acids instead 
of 784 (Fig. 1A). The early termination may also cause accelerated RNA decay and reduced 
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or no protein synthesis.  Regardless of the amount of protein, the truncated protein would 
only contain 13 amino acids from the extracellular domain, and would likely be unstable and 
unable to dimerize precluding normal function. Several human type I cystinuric patients, with 
mutations in the amino terminal region of the protein that cause a premature stop further from 
the amino terminus than in the Labrador Retrievers (and Newfoundlands), show partial or 
complete loss of the rBAT protein.
25
 Only Labrador Retrievers homozygous for the c.350del 
mutation were cystinuric and both males and females, regardless of neuter status, were 
cystinuric and developed cystine calculi early in life, albeit more frequently and earlier in 
males (by 1.1 years in this study) than females, presumably due to anatomic differences 
(Table 2).  Interestingly, the spayed female Labrador Retriever dog developed 
nephrolithiasis, which has also been reported in cystinuric Newfoundland dogs,
13
 but is 
generally rarely reported in dogs with any type of uroliths, in contrast to human patients.   
Moreover, several related Labrador Retrievers were heterozygous for this nonsense 
mutation in the SLC3A1 gene, but neither showed clinical urinary tract signs nor positive 
nitroprusside urine tests.  This is consistent with an autosomal recessive mode of inheritance 
as previously reported for the Newfoundland breed.
13,18
 Based upon information from urolith 
analysis laboratories and particularly when considering the large popularity of the Labrador 
Retriever breed, the incidence of cystinuria in this breed appears low.
8,26
 In contrast, a breed 
predisposition to cystinuria had been recognized in the Newfoundland breed, with at least one 
known popular stud dog that was either cystinuric.
18
 While the information presented here 
can be used to devise genetic tests differentiating between affected, carrier (asymptomatic) 
and normal dogs, general screening of the population of pedigreed Labrador Retrievers is 
currently not recommended. Those Labrador Retrievers showing clinical signs of cystinuria 
and any related dogs should be screened by urine testing followed by DNA testing. And since 
the mutation seems rare, it is reasonable to consider elimination of carrier and affected dogs 
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from the large breeding stock of Labrador Retrievers without depleting the gene pool of the 
breed.
 
The cystinuric Australian Cattle Dogs had an in-frame 6 bp deletion removing 2 of 
the 3 adjacent threonine residues in exon 6 of the SLC3A1 gene (Fig. 1B). This mutation may 
have occurred during DNA replication by mispairing or polymerase “slippage” within the 
repeat of a CAC sequence. This portion of the rBAT protein is found in a highly conserved 
portion of the extracellular domain among all mammals and other vertebrates (Fig. 4A). Due 
to the fact that the deleted amino acids are in the extracellular part of the rBAT protein, 
which is responsible for substrate trafficking,
27
 this deletion may interfere with normal 
transport function, but is not predicted to prevent heterodimerization between rBAT and 
b
0,+
AT as the binding and anchoring sites remain unaffected. All dogs, male and female, 
homozygous or heterozygous for this deletion were cystinuric, but all homozygous males and 
the one homozygous female had higher urinary cystine and COLA values than the 
heterozygous dogs (Table 2). Moreover, the homozygous males showed obstruction earlier in 
life than heterozygous male Australian Cattle Dogs. The later age of onset of clinical signs in 
the homozygous female Australian Cattle Dog may be explained by the differences in 
gender-related urinary tract anatomies. The heterozygous offspring of AUCD 2 was 3 months 
old when tested negative by nitroprusside test and he was unfortunately not available for 
follow up cystine and COLA testing. As the tested mother showed a normal genotype and 
cyanide nitroprusside test, the father of AUCD 2 was likely heterozygous for the deletion and 
therefore cystinuric, but he was also not available for study. We sequenced all exons of the 
SLC3A1 and SLC7A9 genes from homozygous and heterozygous Australian Cattle Dogs and 
did not discover any additional variations in the coding sequence in either allele or gene 
(Table 3). This excludes the possibility of having a compound heterozygote with 2 different 
mutations in the same gene (common in people) or one in the SLC3A1 and one in the SLC7A9 
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gene.
28
 From that we infer that cystinuria in the Australian Cattle Dog is inherited in an 
autosomal dominant trait. No 6 bp deletion in the same region of the SLC3A1 gene has been 
reported in human patients (the human sequence does not contain the triplet repeat), but a 
large duplication of 5 exons involving the A domain has been shown to cause severe 
cystinuria in homozygous and heterozygous patients.
25,28
 While mutations in the SLC3A1 
gene are typically inherited recessively in human patients, rare dominant traits have been 
documented.
23
  
More Australian Cattle Dogs need to be studied to further corroborate the association 
of the clinical and metabolic effects with the mutation and to determine the mutant allele 
prevalence in the Australian Cattle Dog breed. While announcements for screening in the 
breed magazine and on the breed’s listserve did not lead to any other cystinuric Australian 
Cattle Dogs, the fact that the cystinuric Australian Cattle Dogs studied here were from very 
different parts of the United States, ranging from the Southeast to the far Northwest, indicates 
the defect may be more widespread in the United States.  Therefore, it might be appropriate 
to screen any Australian Cattle Dog intended for breeding or those showing clinical signs 
involving the urinary tract. The established DNA test using a simple fragment length size 
differentiation caused by the 6 bp deletion now can be used to detect affected dogs (Fig. 3) in 
addition to checking urine for cystine crystals or increased COLA concentrations, which 
identifies any cystinuric Australian Cattle Dogs but does not clearly differentiate between 
cystinuric heterozygotes and homozygotes. 
Surprisingly, the mixed breed dog (MIXB 1) that formed cystine calculi early in life 
was found to be also homozygous for the same 6 bp deletion in SLC3A1 (c.1095_1100del). 
However, phenotypically, with small stature and somewhat curly white fur, this dog did not 
resemble an Australian Cattle Dog. Interestingly, this mixed breed dog had more than 3 breed 
contributions from different grandparents (no Australian Cattle Dog), but was also highly 
  22 
homozygous for the 312 analyzed SNPs obtained by the genetic mixed breed test, suggesting 
close inbreeding. Currently it is unclear how a mix between a Miniature Poodle, Chihuahua, 
and Shih Tzu could be so homozygous and more like a purebred dog. Moreover, this MIXB 1 
dog was also homozygous for other variations within the SLC3A1 gene and identical to the 
homozygous cystinuric Australian Cattle Dogs (Table 3). These findings suggest that the 
SLC3A1 haplotypes in MIXB 1 and Australian Cattle Dogs are identical and they share a 
common ancestry rather than being caused by two separate events leading to the same 
mutation. 
Last but not least, we describe here the first putative mutation in the SLC7A9 gene 
associated with autosomal dominant cystinuria in Miniature Pinschers from Europe. It is a 
single base missense mutation (c.964G>A) changing the small hydrophobic glycine residue 
to the larger and charged basic amino acid arginine (G322R) in the transmembrane domain 9 
of the light subunit b
o,+
AT (Fig. 1C), which is highly conserved in all mammals and other 
vertebrates, including, chicken, a Xenopus species, and zebrafish (Fig 4B).  According to 
SIFT
p
 analysis, which predicts the consequences of gene mutations on protein function based 
on known protein and evolutionary conservation and three-dimensional structure, this 
substitution is not tolerated to sustain normal function, while protein stability seems 
unaffected.  
In the family of Miniature Pinschers studied here, there were several cystinuric 
heterozygous dogs, but interestingly no homozygous cystinuric dogs were found.  The 
mutation segregated with increased urine cystine levels through the entire pedigree, tracing 
back to a common heterozygous dam. Therefore this missense mutation appears to cause an 
autosomal dominant form of cystinuria (Fig. 2).  In this study, there were no matings between 
heterozygous dogs, so at this time, we have not been able to observe the phenotype of a dog 
homozygous for the mutation. While for dominantly inherited traits, homozygosity for the 
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disease-causing allele can be lethal, this seems unlikely in cystinuria, as homozygous 
individuals with SLC7A9 mutations have been observed in humans.
23,25
 
In cystinuric humans, mutations in transmembrane domains have been described in 
the SLC7A9 gene with homozygous individuals having severe clinical signs, while 
heterozygotes are mildly cystinuric and less commonly develop cystine calculi and at a later 
age.
23,29,30
 It is unclear why this mutation causes a dominant type of cystinuria in dogs, 
although we can put forward at least one plausible hypothesis: because this missense 
mutation does not affect the binding site to rBAT, it likely results in a malfunctional 
transporter channel, rather than inhibiting heterodimerization of the two subunits. Having a 
malfunctioning and normal functioning b
0,+
AT protein anchored in the membrane, may result 
in defective transport. Furthermore, it has been suggested that the COLA transporter is a 
heterotetramer formed from two heterodimers, potentially explaining abnormal or diminished 
transport when mutant and normal dimers interact.
31
 In contrast, null mutations would not 
interfere and thus result in a recessive trait with intermediate normal activity.  As indicated, 
all Miniature Pinschers heterozygous for the missense mutation in the SLC7A9 gene were 
cystinuric, and some repeatedly developed cystine calculi independent of gender and neuter 
status. The degree of COLA-excretion was less severe than with the SLC3A1 mutations 
described above, but surprisingly seemed to cause a relatively higher elevation of cystine 
compared to ornithine, lysine and arginine (Table 2). This is the reverse what is observed in 
cystinuric Newfoundlands and dogs of other breeds studied here, where the sum of the 
dibasic amino acids always exceeds that of cystine alone. Further studies of this mutation in 
Miniature Pinschers are needed to define the molecular mechanism in this first dominant 
canine cystinuria-associated mutation altering the b
0,+
AT protein.  
The prevalence of cystinuria in the Miniature Pinscher breed is currently unknown, 
but it is not a breed that has been reported to have a higher incidence of cystine stones by any 
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urolith analysis laboratory.
11,26
 All cystinuric Miniature Pinschers studied belonged to the 
same family, and we identified a cystinuric heterozygote as a common ancestor.  This dam 
was 11 years old when tested and its parents or other informative relatives were not available; 
hence we do not know, if this mutation originated in this dog, any of its ancestors or even in 
the line of the common sire with an unknown genotype (Fig. 2). Either sequencing of the 
DNA fragment surrounding the mutation or real time PCR based assays can be used for the 
screening of this mutation.  Based upon our current knowledge, all Miniature Pinschers 
related to this family in Europe should be screened by mutation-specific DNA test, 
particularly when related to any cystinuric dogs. And because it is a dominant trait, all dogs 
homozygous or heterozygous for the mutation should be excluded from breeding. 
We had previously divided cystinuria in dogs into 2 types, with type I referring to an 
SLC3A1 mutation and autosomal recessive inheritance and non-type I cystinuria in Mastiffs 
and related breeds, Scottish Deerhounds, and Irish Terriers
a
 exhibiting a milder degree of 
cystinuria solely in mature non-neutered male dogs (PH, UG, unpublished data).
14
 The 
metabolic and genetic studies reported here in 3 additional canine breeds clearly expand our 
understanding of the heterogeneity of cystinuria in dogs. Moreover, the molecular basis of 
cystinuria in many breeds has not been elucidated. For example, the fact that the average age 
of stone-formation in the breeds with known associated mutations is much lower than the 
reported mean age of dogs when cystine calculi are removed (4.8 years to 5.6 years),
7,32,33
 
and that several breeds have been shown to be free from protein-coding mutations in the 
SLC3A1 and SCL7A9 genes,
12,21
 indicates that  the basis for additional heterogeneity in 
canine cystinuria remains to be elucidated. 
And while cystinuria is also complex in humans and several classification systems 
have been proposed, no sex linked or sex limited forms of the disease have been identified.
3,23
 
We therefore propose here a classification system that encompasses both discriminating 
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aspects of the phenotype (for example, gender affected, androgen dependence, and mode of 
inheritance) and the gene associated with the disease (Table 4). We designate type I 
cystinuria when the disease shows autosomal recessive inheritance, Type II when it is 
autosomal dominant, and Type III for sex-limited, androgen dependent inheritance (PH, UG, 
unpublished data). Additional types can be assigned if found. Specific mutations within each 
type should lead to phenotypes that are sufficiently similar that the same medical 
management and breeding advice applies to all cases within that type. Involvement of the 
SLC3A1 gene is indicated by adding –A, and similarly addendum of –B indicated 
involvement of mutations in SLC7A9.  If no letter is appended, the genetic basis is unknown. 
Again, if additional genes are shown to be associated with cystinuria, additional letters can be 
assigned. Alternatively, stating simply the mode of inheritance and mutant gene could be 
used: autosomal recessive and dominant SLC3A1 or dominant SLC7A9 cystinuria and 
androgen-dependent cystinuria, where the molecular genetic defect has not been determined. 
These recent discoveries will have major clinical impacts including selection of the best 
clinical management and genetic control of cystinuria in future generations. 
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Table 1 – Primers and annealing temperatures used for the amplification of the SLC3A1 and SLC7A9 exons from gDNA. 
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Table 2 – Comparison of clinicalpathologic, metabolic and genetic findings in cystinuric Labrador Retrievers, Labrador mixed breed 
dogs, Australian Cattle Dogs and Miniature Pinschers (M=male, MC=male castrated, F=female, FS=female spayed, 1/1=normal 
genotype, 1/2=heterozygous for the mutation, 2/2=homozygous for the mutation);  
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Table 3 – Differences in the coding and flanking intronic sequences of SLC3A1 and SLC7A9 of 5 cystine  
stone formers (LABR 2, LABX 1, AUCD 1, AUCD 5, MIXB 1 and MINP 8) to the canine genome reference sequence. 
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Table 4 
!
Table 4 – New expanded classification system for canine cystinuria according to the novel metabolic and genetic findings (nd = not 
determined). 
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Fig. 1 – Sequencing chromatograms displaying the mutations found and their effect on the protein sequence. A) A 1 bp deletion in 
SLC3A1 exon 1 in purebred and mixed breed Labrador Retriever and causing a frameshift and a premature stop codon to truncate the 
translated protein. B) A 6 bp in frame deletion in SLC3A1 exon 6 in Australian Cattle Dogs and a mixed breed dog deleting 2 
threonines in a repeat of 3. C) A single nucleotide exchange in SLC7A9 exon 9 found heterozygous in cystinuric Miniature Pinschers, 
changing the amino acid from glycin to arginine. 
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!
!
!
Fig. 2 – Pedigree of the Miniature Pinscher family displaying the genotype and the phenotype of the dogs studied, showing their 
correlation and the inheritance in an autosomal dominant trait 
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!
!
!
!
!
Fig. 3 – Fragment length analysis on a 5% polyacrylamid gel, discriminating the normal DNA amplicon of 140 bp from the smaller 
fragment of 134 bp in presence of the 6 bp deletion in SLC3A1 exon 6 found in cystinuric Australian Cattle Dogs (see AUCD #) and a 
mixed breed dog (here Mx) 
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Fig. 4 – Alignment of the amino acid sequences from different species, surrounding A) the deletion of two threonines, found in 
SLC3A1 exon 6 in cystinuric Australian Cattle Dogs and a mixed breed dog, and B) the exchange of a glycine to an arginine, found in 
cystinuric Miniature Pinschers, both showing a highly conserved sequence in the protein. 
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